Roles of tumor necrosis factor alpha (TNF-α) and the p55 TNF receptor in CD1d induction and coxsackievirus B3-induced myocarditis

Journal of Virology

Volumn 79, Issue 5, 2005, Pages 2659-2665

  Huber, S A ^a   Sartini, D ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL DEATH; COXSACKIE VIRUS B3; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; IMMUNE RESPONSE; MALE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS MYOCARDITIS;

ANIMALS; ANTIGENS, CD1; CELL DEATH; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; HEART; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDITIS; MYOCARDIUM; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; COXSACKIEVIRUS; RNA VIRUSES;

EID: 13944277995     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.5.2659-2665.2005     Document Type: Article

References (30)

1. Bergelson, J. M., J. G. Mohanty, R. L. Crowell, N. F. St. John, D. M. Lublin, and R. W. Finberg. 1995. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J. Virol. 69:1903-1906.
2. Chen, S., M. Sega, and A. Agarwal. 2004. "Lumen digestion" technique for isolation of aortic endothelial cells from heme oxygenase-1 knockout mice. BioTechniques 37:84-86, 88-89.
3. Choi, J. J., C. F. Reich III, and D. S. Pisetsky. 2004. Release of DNA from dead and dying lymphocyte and monocyte cell lines in vitro. Scand J Immunol 60:159-166.
4. Davis, L. S., S. S. Patel, J. P. Atkinson, and P. E. Lipsky. 1988. Decay-accelerating actor functions as a signal transducing molecule for human T cells. J. Immunol. 141:2246-2252.
5. Exley, M., N. Bigley, O. Cheng, S. Tahir, S. Smiley, Q. Carter, H. Stills, M. Grusby, Y. Koezuka, M. Taniguchi, and S. Balk. 2001. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J. Leukoc. Biol. 69:713-718.
6. Exley, M., S. Porcelli, M. Furman, J. Garcia, and S. Balk. 1998. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing the invariant Valpha 24Jalpha Q T cell receptor alpha chains. J. Exp. Med. 188:867-876.
7. Exley, M. A., Q. He, O. Cheng, R. J. Wang, C. P. Cheney, S. P. Balk, and M. J. Koziel. 2002. Cutting edge: compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver. J. Immunol. 168:1519-1523.
8. Feuer, R., I. Mena, R. Pagarigan, M. K. Slifka, and J. L. Whitton. 2002. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J. Virol. 76:4430-4440.
9. + T lymphocytes in coxsackievirus B3-induced myocarditis. J. Virol. 69:6720-6728.
10. Huber, S. 2000. T cells expressing the gamma-delta T cell receptor induce apoptosis in cardiac myocytes. Cardiovasc. Res. 45:579-587.
11. + Th cell phenotype and susceptibility of BALB/c mice to coxsackievirus B3-induced myocarditis. J. Virol. 75:5860-5868.
12. + T cells promote susceptibility to coxsackievirus B3-induced myocarditis in mice. J. Immunol. 165:4174-4181.
13. Huber, S., and P. Lodge. 1984. Coxsackievirus B3 myocarditis in Balb/c mice: evidence for autoimmunity to myocyte antigens. Am. J. Pathol. 116:21.
14. Huber, S., A. Moraska, and M. Cunningham. 1994. Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 (CVB3) mutants selected with monoclonal antibodies to group A streptococci. Proc. Natl. Acad. Sci. USA 91:5543-5547.
15. Huber, S., D. Sartini, and M. Exley. 2003. Role of CD1d in coxsackievirus B3-induced myocarditis. J. Immunol. 170:3147-3153.
16. Huber, S., C. Shi, and R. C. Budd. 2002. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J. Virol. 76:6487-6494.
17. Huber, S. A. 2004. Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: role for CD1d. Med Microbiol Immunol (Berlin), in press.
18. + Th1 cells. J. Virol. 76:10785-10790.
19. Knowlton, K. U., E. S. Jeon, N. Berkley, R. Wessely, and S. Huber. 1996. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J. Virol. 70:7811-7818.
20. Kumar, A., V. Thota, L. Dee, J. Olson, E. Uretz, and J. E. Parrillo. 1996. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J. Exp. Med. 183:949-958.
21. Lane, J., D. Neumann, A. Lafond-Walker, A. Herkowitz, and N. Rose. 1992. Interleukin 1 or tumor necrosis factor can promote coxsackie B3-induced myocarditis in resistant B10. A mice. J. Exp., Med. 175:1123-1129.
22. Lane, J., D. Neumann, A. Lanfond-Walker, A. Herskowitz, and N. Rose. 1993. Role of IL-1 and tumor necrosis factor in coxsackievirus-induced autoimmune myocarditis. J. Immunol. 151:1682-1690.
23. Lindberg, A., R. Crowell, R. Zell, R. Kandolf, and U. Pettersson. 1992. Mapping the RD phenotype of the Nancy strain of coxsackievirus B3. Virus Res. 24:187-196.
24. Meldrum, D. R. 1998. Tumor necrosis factor in the heart. Am. J. Physiol. 274:R577-R595.
25. Neumann, D., G. Allen, C. Narins, N. Rose, and A. Herskowitz. 1993. Heart autoantibodies in human myocarditis and cardiomyopathy: virus and skeletal muscle cross-reactivity, p. 325-334. In H. Figulla, R. Kandolf, and B. McManus (ed.), Idiopathic dilated cardiomyopathy. Springer-Verlag, Berlin, Germany.
26. Su, X.-M., and S. Sriram. 1991. Treatment of chronic relapsing experimental allergic encephalomyelitis with the intravenous administration of splenocytes coupled to encephalitogenic peptide 91-103 of myelin basic protein. J. Neuroimmunol. 34:181.
27. Takehana, H., T. Inomata, H. Niwano, M. Nishii, C. Matsuda, K. Kohno, Y. Machida, and T. Izumi. 2002. Immunomodulatory effect of pentoxifylline in suppressing experimental autoimmune myocarditis. Circ. J. 66:499-504.
28. Van Houten, N., P. Bouchard, A. Moraska, and S. Huber. 1991. Selection of an attenuated coxsackievirus B3 variant using a monoclonal antibody reactive to myocyte antigen. J. Virol. 65:1286-1290.
29. Wada, H., K. Saito, T. Kanda, I. Kobayashi, H. Fujii, S. Fujigaki, N. Maekawa, H. Takatsu, H. Fujiwara, K. Sekikawa, and M. Seishima. 2001. Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viral myocarditis in mice: a study using mice lacking TNF-alpha. Circulation 103:743-749.
30. Weller, A., K. Simpson, M. Herzum, N. Van Houten, and S. Huber. 1989. Coxsackievirus B3 induced myocarditis: virus receptor antibodies modulate myocarditis. J. Immunol. 143:1843-1850.